Immunomorphological features of women's skin with androgenetic alopecia in the treatment of plasma enriched with platelets in combination with topical minoxidil 2 % lotion
Abstract
Introduction. The skin biopsies of 30 patients with androgenetic alopecia before and after treatment with platelet-rich plasma in combination with 2 % minoxidil were examined by immunohistochemistry. Goal. The study looked at immunohistochemical changes in the scalp biopsies of patients with stage I-II androgenetic alopecia according to the Ludwig scale and to identify possible changes after injection of platelet-rich plasma in combination with topical 2 % minoxidil lotion. Materials and methods. Skin biopsies of 30 patients with androgenetic alopecia were examined using an immunohistochemical study before and after treatment, which lasted 3 months and included 3 sessions of PRP (once per month) and topical application of minoxidil 2 % lotion twice a day. Results. It was found that androgenetic alorecia is accompanied by inflammatory perifollicular infiltration by T-lymphocytes CD3 +, CD4 + and CD8 +, macrophages (CD68 +); imbalance of germ polypeptides VEGF, TGF-β1, EGFR; accumulation of oxidative stress enzymes eNOS and iNOS; accumulation of pathological fraction of collagen IV. Injections of platelet-rich plasma in combination with topical administration of 2 % minoxidil as a treatment for androgenetic alopecia lead to normalization of immunohistochemical parameters of the skin, which indicates the possibility of using this combination for long-term therapeutic effect. Conclusions. This study complemented the understanding of the pathogenesis of AGA and serves as a basis for improving treatment regimens for this pathology. However, additional studies are needed to further study the pathomorphology of androgenetic alopecia and to standardize the technique of using platelet-rich plasma in patients with this disease.
Downloads
References
Avtandilov GG. Osnovy kolichestvennoi patolohicheskoi anatomii. Moskva: Medicina; 2002. 240 s. [in Russian].
Ovcharenko YuS, Kachuk YuV. Androheneticheskaia alopeciia. Les Nouvelles Esthetiques (Ukraina). 2015; 3 (91): 70–8 [in Russian].
Serebrianaia NB, Shanin SN, Fomicheva EE, Iakuceni PP. Trombocity kak aktivatory i rehuliatory vospalitel`nykh i immunnykh reakcii. Chast` 1, Osnovnye kharakteristiki trombocitov kak vospalitel`nykh kletok. Med immunolohiia. 2018; 20 (6): 785–96 [in Russian].
Zlotohorskii A, Shapiro D, Litus A, Ovcharenko Yu. Trikhologiia. 2-e izd., dop. i pererab. Kiev: Kiev; 2016. 276 s. [in Russian].
Agabalyan NA, Borys BS, Sparks HD, Boon K, Raharjo EW, et al. Enhanced Expansion and Sustained Inductive Function of Skin-Derived Precursor Cells in Computer-Controlled Stirred Suspension Bioreactors. Stem Cells Transl Med. 2017; 6 (2): 434−43.
Alves R, Grimalt R. Randomized Placebo-Controlled, Double-Blind, Half-Head Study to Assess the Efficacy of Platelet-Rich Plasma on the Treatment of Androgenetic Alopecia. Dermftol Surg. 2016 Apr; 42 (4): 491–7. Doi: https://doi.org/10.1097/DSS.0000000000000665.
Anitua E, Pino A, Martinez N, Orive G, Berridi D. The effect of plasma rich in growth factors on pattern hair loss: a pilot study. Dermatol Surg. 2017; 43: 658–70.
Doi: https://doi.org/10.1097/DSS.0000000000001049.
do Nascimento I, Harries M, Rocha VB, Thompson JY, Wong CH., Varkaneh HK, et al. Effect of Oral Minoxidil for Alopecia: Systematic Review. Int J Trichology. 2020; 12 (4): 147–55. Doi: https://doi.org/10.4103/ijt.ijt_19_20.
Gentile P, Garcovich S, Bielli A, Scioli MG, Orlandi A, Cervelli V. The effect of platelet-rich plasma in hair regrowth: a randomized placebo-controlled trial. Stem Cells Transl Med. 2015; 4: 1317–23. Doi: https://doi.org/10.5966/sctm.2015-0107.
Gupta S, Revathi TN, Sacchidanand S, Nataraj HV. A study of the efficacy of platelet-rich plasma in the treatment of androgenic alopecia in males. Indian J Dermatol Venereol Leprol. 2017;83(3):412. Doi: https://doi.org/10.4103/0378-6323.191128.
Jin M, Chen Y-L, He X, Hou Y, Chan Z, Zeng R. Amelioration of Androgenetic Alopecia by Algal Oligosaccharides Prepared by Deep-Sea Bacterium Biodegradation. Front Microbiol. 2020; 11: 567060. Doi: https://doi.org/10.3389/fmicb.2020.567060.
Kim BJ, Kim SY, Kwon TR, Lee YH, Song YS. Platelet-rich plasma promoting hair growth in human hair follicle dermal papilla cells associated with VEGF and VEGFR-2. J Invest Dermatol. 2013; 133: 1398.
Lee SH, Zheng Z, Kang J-S, Kim D-Y, Oh SH, Cho SB. Therapeutic efficacy of autologous platelet-rich plasma and polydeoxyribonucleotide on female pattern hair loss. Wound Repair Regen. 2015; 23 (1): 30–6. Doi: https://doi.org/10.1111/wrr.12250.
Mapar MA, Shahriari S, Haghighizadeh MH. Efficacy of platelet-rich plasma in the treatment of androgenetic (male-patterned) alopecia: a pilot randomized controlled trial. J Cosmet Laser Ther. 2016; 18 (8): 452–5. Doi: https://doi.org/10.1080/14764172.2016.1225963.
Najem I, Chen H. Use of low-level laser therapy in treatment of the androgenic alopecia, the first systematic review. J Cosmet Laser Ther. 2018 Aug; 20 (4): 252–7. Doi: https://doi.org/10.1080/14764172.2017.1400174.
Ovcharenko J, Salenkova O. Аutologous platelet-rich plasma: a review of scientific articles on the study of efficiency in treatment of androgenetic alopecia in men and women. Journal of V. N. Karazin` KhNU. 2018; 36: 72–9. Doi: https://doi.org/10.26565/2313-6693-2018-36-11.
Panchaprateep R, Lueangarun S. Efficacy and Safety of Oral Minoxidil 5 mg Once Daily in the Treatment of Male Patients with Androgenetic Alopecia: An Open-Label and Global Photographic Assessment. Dermatol Ther (Heidelb). 2020; 10 (6): 1345–57. Doi: https://doi.org/10.1007/s13555-020-00448-x.
Puig CJ, Reese R, Peters M. Double-blind, placebo-controlled pilot study on the use of platelet-rich plasma in women with female androgenetic alopecia. Dermatol Surg. 2016; 42: 1243–7. Doi: https://doi.org/10.1097/DSS.0000000000000883.
Sadick NS, Callender VD, Kircik LH, Kogan S. New Insight Into the Pathophysiology of Hair Loss Trigger a Paradigm Shift in the Treatment Approach. J Drugs Dermatol. 2017; 16 (11 Suppl):s. 135–40.
Sperling LC, Lupton GP. Histopathology of nonscarring alopecia. J Cutan Pathol. 1995 Apr; 22 (2): 97–114. Doi: https://doi.org/10.1111/j.1600-0560.1995.tb01391.x.
Tanaka Y, Aso T, Ono J, Hosoi R, Kaneko T. Androgenetic Alopecia Treatment in Asian Men. The Journal of clinical and aesthetic dermatology. 2018;11(7):32–5.
Trink A, Sorbellini E, Bezzola P, Rodella L, Rezzani R, Ramot Y, et al. A randomized, double blind, placebo- and active-controlled, half-head study to evaluate the effect of platelet-rich plasma on alopecia areata. Br J Dermatol. 2013; 169 (3): 690–4. Doi: https://doi.org/10.1111/bjd.12397.
Yoon JS, Ku WY, Lee JH, Ahn HC. Low-level light therapy using a helmet-type device for the treatment of androgenetic alopecia: A 16-week, multicenter, randomized, double-blind, sham device-controlled trial. Medicine (Baltimore). 2020 Jul 17; 99 (29): e21181. Doi: https://doi.org/10.1097/MD.0000000000021181
The Journal of V. N. Karazin Kharkiv National University, series Medicine has following copyright terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work’s authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work, with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.